SPR Therapeutics Inc. has closed a $2.2 million Series A investment round that it will use as it works to win regulatory approval for a product designed to alleviate pain through neurostimulation.
The company in Highland Hills expects in the second quarter to win approval to sell its first product, the Smartpatch Peripheral Nerve Stimulation System, in Europe. The startup expects to gain approval to sell the product in the United States in early 2013, said SPR chief executive officer Maria Bennett....
SPR, which employs five people, is looking for a strategic partner that could provide the company with the sales and marketing expertise needed to commercialize the product, Ms. Bennett said, noting that the company is open to acquisition as well....
Read the complete story.